Cryo-Cell

CCEL

4.6801.47% ( -0.070 )

Closed: Oct 21, 16:00:00 (EDT)

Current ValuationThe current P/E ratio is -19.69, within the reasonable range, cheaper than 78.9% of the time in the past 3 years, and the industry ranks 53/74, the industry Median --.

-19.69xP/E

Stock price$4.75Earnings per share$-0.24

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.

07142128

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.

0x40x80x120x160x200x

P/E ratio
Name/Symbol
GHUSGuardant Health	-48.12x	2.97%	$21.82B
HIMSUSHims & Hers Health	-47.98x	209.86%	$6.82B
RDNTUSRadnet	-259.58x	128.00%	$5.48B
NEOUSNeogenomics	-41.16x	64.12%	$2.14B
WGSUSGeneDx	-19.27x	359.59%	$2.05B
AGLUSagilon health	-6.63x	92.48%	$1.54B
INNVUSInnovage	-492.13x	2,301.70%	$1.25B
OPKUSOpko Health	-17.00x	25.99%	$1.24B
LMRIUSLumexa Imaging	-37.00x	145.51%	$1.03B
CSTLUSCastle Biosciences	-52.16x	51.54%	$1.01B
GMRSUSGMR Solutions	-7.48x	91.45%	$566.15M
FLGTUSFulgent Genetics	-6.63x	42.64%	$559.39M
PREUSPrenetics Global	-6.80x	15.02%	$319.38M
AONCUSAmerican Oncology Network	--	--	$271.09M
BDSXUSBiodesix	-9.07x	42.77%	$251.86M
GAMGUSGlobal Asset Management Group, Inc.	-343.77x	--	$194.04M
NAKAUSNakamoto	-0.30x	102.50%	$127.77M
CORBFUSGlobal Cord Blood Corporation	--	--	$127.35M
PARKUSPark Dental Partners	-26.90x	--	$95.11M
AIRSUSAirSculpt Tech	-7.98x	33.33%	$93.72M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.